John is the co-founder and Chief Technology and Development Officer at Impel Neuropharma. He holds a BS in Physics from the University of Minnesota and graduated with a Ph.D. in Pharmaceutics from the University of Washington in 2010. John co-founded Impel while attending graduate school at the University of Washington in 2008. Along with mechanistic and pharmacokinetic studies, he has developed formulations and drug delivery devices to enable more efficient drug delivery via the nasal passages. John has spent the last 10 years working across all functions to grow Impel from a pre-clinical device focused company to a late-clinical stage pharmaceutical company. John is the inventor on 42 issued patents related to drug delivery.